Facilitating Access to Approved Medication

Venetoclax Tablets 100 mg
Venetoclax Tablets is used alone or together with other medicines (eg, rituximab) to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, in patients who have received at least one previous treatment.

Get Access To Venetoclax Tablets 100 mg

Venetoclax Tablets was approved for medical use in the United States in 2016. It is on the World Health Organization’s List of Essential Medicines.

Venetoclax Tablets Available Price In India UK Saudi Arabia

Venetoclax Tablets

  • API – Venetoclax Tablets
  • Packaging – (28*4) 112 Tablets
  • Strength –  100 mg
  • Brand name available – On Request

What is Venetoclax Tablets used for?

Venetoclax Tablets are prescription medicine used: to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).


    All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.

    Get Access To Venetoclax Tablets 100 mg

    Shreyaansh Lifesciences, Jaipur. India

    Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act. 
    Branch Offices in India : Jaipur | New Delhi

    SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.

    +91 99292 77766

    Facts of Medicines

    Venetoclax Tablets 100 mg


    Venetoclax Tablets should be stored at 20° to 25°C (68° to 77°F); excursions permitted to 15°to 30° C (59° to 86° F) [ Controlled Room Temperature]. Keep away from children.


    • The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). To reduce your risk of side effects, your doctor may direct you to start this medication at a low dose and gradually increase your dose. Follow your doctor’s instructions carefully.
    • Use this medication regularly to get the most benefit from it. To help you remember, take it at the same time each day.
    • Do not increase your dose or use this drug more often or for longer than prescribed. Your condition will not improve any faster, and your risk of serious side effects will increase.
    • Avoid eating/drinking grapefruit products, Seville oranges (often found in marmalade), or starfruit while using this medication unless your doctor or pharmacist says you may do so safely. These can increase the chance of side effects with this medicine. Ask your doctor or pharmacist for more details.


    The following clinically significant adverse reactions can occur with Venetoclax Tablets: Cardiovascular Toxicity, Myelosuppression, Hypersensitivity, Hypertension, Pancreatic Toxicity.


    • Genetic testing should be indicated in order to detect whether a person is at higher risk of developing hypersensitivity.
    • Venetoclax Tablets may not be added as a single agent when antiretroviral regimens are changed because of loss of the virologic response.
    • Patients with liver disease should be watchful and cautious in order to Venetoclax Tablets because it can aggravate the condition.
    • In patients with Venetoclax Tablets, conditions like immune reconstitution inflammatory syndrome, a change in body fat as well as an increased risk of heart attack may occur.
    • Venetoclax Tablets is not recommended for use in infants who are under 3 months of age.
    • Cases like lactic acidosis and severe hepatomegaly with steatosis occurred with the use of nucleoside analogues.
    • Sometimes serious hypersensitivity reactions have been associated with Venetoclax Tablets.

    FAQs – Medicine Questions

    Venetoclax Tablets 100 mg
    Is venetoclax a chemotherapy?
    Technically, Venclexta (venetoclax) is a type of targeted treatment rather than chemotherapy. Chemotherapy is defined as a drug treatment that kills fast-growing cells in your body, which means that it often kills other normal cells in your body that are fast-growing, such as red blood cells and cells in your hair.
    How long do you take venetoclax?
    Adults—At first, 20 milligrams (mg) once a day. Your doctor will gradually increase your dose each week for 5 weeks (ramp-up). However, the dose is usually not more than 400 mg per day. Children—Use and dose must be determined by your doctor.
    Does venetoclax cause hair loss?
    You should not experience hair loss with Venclexta. Hair loss was not a side effect seen in clinical trials of people taking Venclexta. Other medications that may be used to treat cancer may cause hair loss to occur. These can include chemotherapy.
    Where can I buy Venetoclax Tablets?

    You can buy Venetoclax Tablets from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.

    The buyer should check the existing law in their home country before importing the product.

    What is the procedure to buy Venetoclax Tablets?

    Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 99292 77766 / 98738 10020   We will reply ASAP with the details of the Venetoclax Tablets price as well as procurement procedure.

    Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.

    How quickly does venetoclax work?
    How fast does Venclexta work for AML? It took an average of one month (range 0.7 to 8.9 months) for patients to experience a clinical remission in patients assigned to V+A. It took an average of 1.9 months (range 0.8 to 4.2 months) for patients to experience a clinical remission in patients assigned to V+D.